![](/img/cover-not-exists.png)
P-565 A Phase II study of KOS-862 (Epothilone D) as second-linetherapy in non-small cell lung cancer
Rizvi, N., Villalona-Calero, M., Lynch, T., Yee, L., Gabrail, N., Sandler, A., Cropp, G., Graham, M., Palmer, G.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)81058-x
Date:
July, 2005
File:
PDF, 281 KB
english, 2005